GSK Shares Outstanding 2010-2022 | GSK

GSK shares outstanding history from 2010 to 2022. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • GSK shares outstanding for the quarter ending June 30, 2022 were 2.013B, a 0.46% decline year-over-year.
  • GSK 2021 shares outstanding were 2.001B, a 0.69% decline from 2020.
  • GSK 2020 shares outstanding were 2.015B, a 0.44% increase from 2019.
  • GSK 2019 shares outstanding were 2.006B, a 0.91% increase from 2018.
GSK Annual Shares Outstanding
(Millions of Shares)
2021 2,001
2020 2,015
2019 2,006
2018 1,988
2017 1,976
2016 1,964
2015 1,955
2014 1,946
2013 1,968
2012 1,965
2011 2,040
2010 2,051
2009 2,077
GSK Quarterly Shares Outstanding
(Millions of Shares)
2022-06-30 2,013
2022-03-31 2,008
2021-12-31 2,001
2021-09-30 2,024
2021-06-30 2,022
2021-03-31 1,997
2020-12-31 2,015
2020-09-30 2,016
2020-06-30 2,012
2020-03-31 2,004
2019-12-31 2,006
2019-09-30 2,003
2019-06-30 1,996
2019-03-31 1,991
2018-12-31 1,988
2018-09-30 1,967
2018-06-30 1,984
2018-03-31 1,978
2017-12-31 1,976
2017-09-30 1,974
2017-06-30 1,955
2017-03-31 1,967
2016-12-31 1,966
2016-09-30 1,961
2016-06-30 1,944
2016-03-31 1,956
2015-12-31 1,935
2015-09-30 1,951
2015-06-30 1,950
2015-03-31 1,928
2014-12-31 1,924
2014-09-30 1,946
2014-06-30 1,925
2014-03-31 1,950
2013-12-31 1,909
2013-09-30 1,969
2013-06-30 1,972
2013-03-31 1,939
2012-12-31 1,937
2012-09-30 1,989
2012-06-30 1,996
2012-03-31 1,985
2011-12-31 2,010
2011-09-30 2,029
2011-06-30 2,029
2011-03-31 2,055
2010-12-31 2,053
2010-09-30 2,135
2010-06-30 1,898
2010-03-31 2,066
2009-12-31 2,095
2009-09-30 2,094
2009-06-30 2,066
2009-03-31 2,101
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $59.709B $46.910B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $150.984B 9.16
Bio-Rad Laboratories (BIO.B) United States $12.433B 27.47
Biohaven Pharmaceutical Holding (BHVN) United States $10.873B 0.00
QIAGEN (QGEN) Netherlands $9.383B 15.71
Ginkgo Bioworks Holdings (DNA) United States $4.998B 0.00
Arcus Biosciences (RCUS) United States $1.819B 35.51
Myovant Sciences (MYOV) United Kingdom $1.614B 0.00
Emergent Biosolutions (EBS) United States $1.040B 6.03
ADC Therapeutics SA (ADCT) Switzerland $0.376B 0.00
Zymeworks (ZYME) Canada $0.305B 0.00
Enzo Biochem (ENZ) United States $0.105B 0.00
Gelesis Holdings (GLS) United States $0.081B 0.00
SQZ Biotechnologies (SQZ) United States $0.068B 0.00
Ambrx Biopharma (AMAM) United States $0.041B 0.00